OverviewChartTechnicalNewsTraderScreen

Adma Biologics Inc/  US0008991046  /

NASDAQ
2024-05-07  9:24:22 PM Chg. -0.0100 Volume Bid9:24:22 PM Ask9:24:22 PM High Low
6.9000USD -0.14% 1.16 mill.
Turnover: 7.04 mill.		 6.9000Bid Size: 2,200 6.9100Ask Size: 5,300 6.9700 6.8600
GlobeNewswire 05-02 ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
GlobeNewswire 03-11 ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ ...
GlobeNewswire 03-05 ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
GlobeNewswire 02-28 ADMA Biologics Announces CFO Transition
GlobeNewswire 02-28 ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business U...
GlobeNewswire 02-21 ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
GlobeNewswire 02-21 ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
GlobeNewswire 2023-12-18 ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Manage...
GlobeNewswire 2023-12-12 ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Year...
GlobeNewswire 2023-11-16 ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
GlobeNewswire 2023-11-08 ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 2023-11-01 ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
GlobeNewswire 2022-03-25 ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM® from 24 to 36 M...
GlobeNewswire 2022-03-24 ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business U...
GlobeNewswire 2022-03-21 ADMA Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022
GlobeNewswire 2022-03-07 ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GA
GlobeNewswire 2022-01-19 ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides ...
GlobeNewswire 2022-01-18 ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek...
GlobeNewswire 2021-12-11 Annual Changes to the Nasdaq Biotechnology Index
GlobeNewswire 2021-12-09 ADMA Biologics Provides Update on Global Intellectual Property Portfolio
GlobeNewswire 2021-12-06 First Wave BioPharma’s CEO and President, James Sapirstein, to Participate in CEO Panel Discussion a...
GlobeNewswire 2021-11-17 ADMA Biologics Senior Vice President of Plasma Services Cyndi Tolman Elected to PPTA Source Board of...
GlobeNewswire 2021-11-16 ADMA Biologics Advances Plasma Collection Center Expansion Plans with Opening of New Facility in Myr...
GlobeNewswire 2021-11-10 ADMA Biologics Reports Record Third Quarter 2021 Financial Results and Highlights Recent Progress an...
GlobeNewswire 2021-11-03 ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021